Sonoma Pharmaceuticals, Inc.
SNOA· Nasdaq
Filed Aug 4, 2011 · 10-Q · 35 days after period end · 0001144204-11-044025
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenue | $2.94M | $2.26M |
| Net Income | -$2.18M | -$2.38M |
| EPS Diluted | -$0.08 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 4, 2011 · 35 d after period end